ArticleJournal of inherited metabolic disease2007
Newborn screening: experiences in the Middle East and North Africa.
Article in Journal of inherited metabolic disease, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed.
- Newborn Screening in Saudi Arabia: Brief History, Current Practice, and Future Direction.International journal of neonatal screening · 2026Review
- Developing and validating a neonatal screening tool for congenital anomalies to be used in low- and middle-income country settings.BMJ global health · 2026Article
- The status of newborn screening in Africa: Situation analysis, future plans and call to action.African journal of laboratory medicine · 2025Article
- Outcomes of cases with elevated 3-hydroxyisovaleryl carnitine report from the newborn screening program.Molecular genetics and metabolism reports · 2024Article
- Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).International journal of neonatal screening · 2024Review
- A retrospective analysis of MS/MS screening for IEM in high-risk areas.BMC medical genomics · 2023Article
- Interventions addressing genetic disease burdens within selected countries in the MENA region: a scoping review.Journal of community genetics · 2023Article
- Expert Group Consensus on early diagnosis and management of infantile-onset pompe disease in the Gulf Region.Orphanet journal of rare diseases · 2022Review
- Review of Kangaroo Mother Care in the Middle East.Nutrients · 2022Review
- Strategies to increase access to basic sickle cell disease care in low- and middle-income countries.Expert review of hematology · 2022Article
- Epidemiology of Phenylketonuria Disease in Jordan: Medical and Nutritional Challenges.Children (Basel, Switzerland) · 2022Article
- Successful Implementation of Expanded Newborn Screening in the Philippines Using Tandem Mass Spectrometry.International journal of neonatal screening · 2022Article
- Genomic medicine in the Middle East.Genome medicine · 2021Article
- Molecular genetics of phenylketonuria and tetrahydrobiopterin deficiency in Jordan.JIMD reports · 2020Article
- The Genetic Landscape and Epidemiology of Phenylketonuria.American journal of human genetics · 2020Article
- Diagnosis and Management of Hypothyroidism in Gulf Cooperation Council (GCC) Countries.Advances in therapy · 2020Review
- Physiology, Development, and Disease Modeling in theGenetics · 2020Review
- Challenges and Opportunities in Establishing and Maintaining Newborn Screening in a Rural Area of Andhra Pradesh - Task Force Study by Indian Council of Medical Research.Indian journal of pediatrics · 2018Article
- Article
- White Paper: Pathways to Progress in Newborn Screening for Sickle Cell Disease in Sub-Saharan Africa.Journal of tropical diseases & public health · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review presents the current experiences with newborn screening in the Middle East and North Africa region. The population in the region is about 400 million, with high birth rate and an estimated 10 million newborns per year. The majority of the population is of the Islamic faith and mostly Arab. The population is characterized by a high consanguinity (25-70%) and a high percentage of first-cousin marriages. Haemoglobin disorders, inherited metabolic disorders, neurogenetic disorders and birth defects are relatively common among the population. There is a rather slow progress in developing and implementing preventive genetic programmes owing to legal, cultural, political and financial issues. Although research spending is rather soft in the region, there are numerous pilot studies that highlighted the high incidence of genetic defects and the need for newborn screening programmes. Currently, there are only four countries that are executing national newborn screening but they vary from one disease to 23 and coverage is not complete. The region needs to take big steps towards developing national strategies for prevention and should learn from experiences of regional and international screening programmes.
Indexed as
Identifiers
17701444What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.